Jiyuan Yang

5.1k citations
113 papers · 4.3k indexed · h-index 39
Topics
RNA Interference and Gene Delivery (21 papers)Nanoparticle-Based Drug Delivery (21 papers)CAR-T cell therapy research (15 papers)

In The Last Decade

Jiyuan Yang

110 papers receiving 4.2k citations

Peers

Jiyuan Yang
Comparison fields: 5 of 113
  • Biomaterials 2.0k
  • Molecular Biology 1.5k
  • Biomedical Engineering 1.3k
  • Organic Chemistry 740
  • Oncology 600
Replace Shawn C. Owen with:
Shawn C. Owen United States
Blanka Řı́hová Czechia
J. Strohalm Czechia
Han Cheng China
Tetsuji Yamaoka Japan
Jindřich Kopeček United States
Tianmeng Sun China
Tomáš Etrych Czechia
Chao Lin China
Vladimír Šubr Czechia
Jiyuan Yang relative to Shawn C. Owen United States Shawn C. Owen's profile →
Citations per field
00.5×1.7×
Shawn C. Owen · 1×
Citations per year

Countries citing papers authored by Jiyuan Yang

Since Specialization
Citations

This map shows the geographic impact of Jiyuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyuan Yang more than expected).

Fields of papers citing papers by Jiyuan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyuan Yang. The network helps show where Jiyuan Yang may publish in the future.

Co-authorship network of co-authors of Jiyuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyuan Yang. A scholar is included among the top collaborators of Jiyuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyuan Yang. Jiyuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 0
5 2
6 7
7 4
8 18
9 38
10 23
11 15
12 12
13 24
14
Chemotherapy-associated hepatotoxicity in colorectal cancer.
17
15 22
16 4
17 14
18 47
19 22
20 64

About Jiyuan Yang

Jiyuan Yang is a scholar working on Biomaterials, Molecular Medicine and Oncology, having authored 113 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (21 papers), Nanoparticle-Based Drug Delivery (21 papers) and CAR-T cell therapy research (15 papers). The work is most often cited by research in Biomaterials (2.0k citations), Molecular Medicine (574 citations) and Biomedical Engineering (1.3k citations). Jiyuan Yang has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Jindřich Kopeček, Pavla Kopečková, Huaizhong Pan, Yan Zhou, Kui Luo, Monika Sima, Kuangshi Wu, D. Christopher Radford, Yu Lin and Jihua Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026